Brian W. Ellis
Known title: DirectorCIK: 0001662008
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.
Transaction History
| ETR | ▲ Buy | Grant | 218 | $0 | 8/31/2026 | View on chart |
| ETR | ▲ Buy | Grant | 858 | $0 | 6/1/2026 | View on chart |
| ETR | ▲ Buy | Grant | 221 | $0 | 6/1/2026 | View on chart |
| ETR | ▲ Buy | Grant | 217 | $0 | 3/2/2026 | View on chart |
| DHR | ▲ Buy | Grant | 1,695 | $0 | 2/4/2026 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 1,254 | $280K | 2/2/2026 | View on chart |
| ETR | ▲ Buy | Grant | 245 | $0 | 12/1/2025 | View on chart |
| DHR | ▲ Buy | Option Exercise | 7,109 | $417K | 11/12/2025 | View on chart |
| DHR | ▼ Sell | Open Market | 7,109 | $1.6M | 11/12/2025 | View on chart |
| DHR | ▲ Buy | Option Exercise | 14,667 | $859K | 11/12/2025 | View on chart |
| DHR | ▼ Sell | Open Market | 14,667 | $3.2M | 11/12/2025 | View on chart |
| ETR | ▼ Sell | Open Market | 43 | $4K | 10/31/2025 | View on chart |
| ETR | ▲ Buy | Grant | 265 | $0 | 9/2/2025 | View on chart |
| ETR | ▲ Buy | Grant | 279 | $0 | 6/2/2025 | View on chart |
| ETR | ▲ Buy | Grant | 1,023 | $0 | 6/2/2025 | View on chart |
| ETR | ▼ Sell | Open Market | 647 | $53K | 5/30/2025 | View on chart |
| ETR | ▲ Buy | Grant | 265 | $0 | 2/28/2025 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 5,677 | $1.2M | 2/3/2025 | View on chart |
| DHR | ▲ Buy | Option Exercise | 5,700 | $334K | 1/30/2025 | View on chart |
| DHR | ▼ Sell | Open Market | 5,700 | $1.3M | 1/30/2025 | View on chart |
| ETR | ▲ Buy | Grant | 149 | $0 | 11/29/2024 | View on chart |
| ETR | ▲ Buy | Grant | 192 | $0 | 8/30/2024 | View on chart |
| DHR | ▼ Sell | Open Market | 9,600 | $2.6M | 7/25/2024 | View on chart |
| ETR | ▲ Buy | Grant | 195 | $0 | 5/31/2024 | View on chart |
| ETR | ▲ Buy | Grant | 712 | $0 | 5/31/2024 | View on chart |
| DHR | ▼ Sell | Open Market | 4,000 | $1.0M | 4/24/2024 | View on chart |
| ETR | ▲ Buy | Grant | 216 | $0 | 2/29/2024 | View on chart |
| DHR | ▲ Buy | Grant | 3,943 | $0 | 2/21/2024 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 7,634 | $1.9M | 2/1/2024 | View on chart |
| ETR | ▲ Buy | Grant | 216 | $0 | 11/30/2023 | View on chart |
| ETR | ▲ Buy | Grant | 230 | $0 | 8/31/2023 | View on chart |
| ETR | ▲ Buy | Grant | 815 | $0 | 5/31/2023 | View on chart |
| ETR | ▲ Buy | Grant | 223 | $0 | 5/31/2023 | View on chart |
| ETR | ▲ Buy | Grant | 213 | $0 | 2/28/2023 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 665 | $166K | 2/24/2023 | View on chart |
| DHR | ▲ Buy | Grant | 11,050 | $0 | 2/22/2023 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 3,189 | $853K | 2/1/2023 | View on chart |
| ETR | ▲ Buy | Grant | 189 | $0 | 11/30/2022 | View on chart |
| ETR | ▲ Buy | Grant | 190 | $0 | 8/31/2022 | View on chart |
| ETR | ▲ Buy | Grant | 665 | $0 | 5/31/2022 | View on chart |
| ETR | ▲ Buy | Grant | 161 | $0 | 5/31/2022 | View on chart |
| ETR | ▲ Buy | Grant | 185 | $0 | 2/28/2022 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 1,384 | $376K | 2/24/2022 | View on chart |
| DHR | ▲ Buy | Grant | 15,940 | $0 | 2/23/2022 | View on chart |
| DHR | ▼ Sell | Open Market | 5,365 | $1.6M | 2/2/2022 | View on chart |
| DHR | ▼ Sell | Tax Withholding | 3,595 | $1.0M | 2/1/2022 | View on chart |
| ETR | ▲ Buy | Grant | 193 | $0 | 11/30/2021 | View on chart |
| ETR | ▲ Buy | Grant | 176 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Entergy faces rate headwinds as analysts lower price targets
Entergy's solid data center and utility fundamentals are currently overshadowed by rate headwinds, prompting several firms to lower their price targets. JP Morgan, Keybanc, and Truist all maintained positive ratings but reduced their outlooks to $130, $118, and $119, respectively. These adjustments place the new targets below the stock's 52-week high of $118.45, signaling caution despite the company's ongoing sustainability and workforce initiatives.
Entergy faces rate headwinds as analysts lower price targets. Entergy's solid data center and utility fundamentals are currently overshadowed by rate headwinds, prompting several firms to lower their price targets. JP Morgan, Keybanc, and Truist all maintained positive ratings but reduced their outlooks to $130, $118, and $119, respectively. These adjustments place the new targets below the stock's 52-week high of $118.45, signaling caution despite the company's ongoing sustainability and workforce initiatives.